GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medline MDLN · USD

Health Care · US listing · 🇺🇸 United States

Compare

40.71

+2.70%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

34 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 12Strong buy
  • 15Buy
  • 7Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 40.71Average target 46.33

Low
37.00
Average
46.33
Median
45.00
High
60.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$31.23bn$33.69bn$36.30bn$39.06bn$41.94bn
Revenue, highest$31.28bn$33.79bn$37.37bn$39.50bn$42.41bn
Revenue, lowest$31.15bn$33.47bn$35.79bn$38.78bn$41.63bn
Earnings per share1.491.561.792.022.28
Earnings per share, highest1.541.692.042.052.31
Earnings per share, lowest1.361.411.272.002.26
Analysts2020211010

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025
Forecast0.340.350.300.24
Reported0.440.500.330.22
Difference+28.2%+41.9%+11.8%-5.6%

Rating changes

Latest broker notes

  • JP MorganOverweight
  • Wells FargoEqual Weight
  • Tigress FinancialBuy
  • TD CowenBuy
  • Truist SecuritiesBuy
  • StifelBuy
  • RBC CapitalOutperform
  • Evercore ISI GroupOutperform
  • BTIGBuy
  • BairdOutperform
  • BarclaysOverweight
  • BNP ParibasNeutral

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

2 / 10

Revenue growth 0.0% a year over 10 years. Return on equity 10.8%.

Model fair value

41.53

From earnings 41.53, from revenue 41.53.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.